- Teva 5% fall in Q4 2022
- Buy Teva Pharmaceuticals amid news, says
- Teva completes $40.5B Actavis deal, to Anda $500M Philadelphia Business Journal
- Teva Acquisition – PL Developments
- Teva Pharmaceutics USA acquires three buildings an R&D campus in Chester - Philadelphia Business Journal
- jumps after Wall Street upgrades, analysts say stock 'too cheap to
- Teva Pharmaceuticals Stock Buy? The Fool
- Teva Near Lows (NYSE:TEVA) Seeking Alpha
- Teva move HQ from Pennsylvania to New | The Times of Israel
- Teva
- Pharmaceutical Sell-Off, is it to Buy, Sell or Hold? – PGM Capital
- Is Teva Pharmaceutical (TEVA) a Good Buy in the Healthcare
- Gains 6.4% on Another Opioid Case - TipRanks.com
- Pharmaceuticals To Buy Gecko Health Innovations
- Teva Stock Skyrockets After Inking North Of Billion In Opioid Settlements | Investor's Business Daily
- Teva Pharma: Brief The Big Earnings Report Coming In February (NYSE: TEVA) | Alpha
- Pharmaceutical Company Reaches Settlement Oklahoma In Opioid Case : NPR
- Teva offers to Mylan in $40 billion deal | The Times Israel
- Buy, Sell or Hold: Teva Pharmaceutical — Predictions at
- Teva Stock Price Today | NYSE - Investing.com
- Teva Pharmaceuticals liable in New York opioid - BBC News
- Teva's Battered Stock Extremely Cheap
- Teva Allergan, drops Mylan bid
- Teva Pharmaceuticals to Buy Allergan's Generics Business - New Times